# Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women

> **NCT05403047** · PHASE4 · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 150 (estimated)

## Conditions studied

- Hepatitis B Virus - Chronic Active

## Interventions

- **DRUG:** Fumarate, Tenofovir Disoproxil

## Key facts

- **NCT ID:** NCT05403047
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07
- **Primary completion:** 2025-07
- **Final completion:** 2025-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05403047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05403047, "Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05403047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*